Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Acute Lymphocytic Leukemia
>>
ImmunoGen
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
Sarclisa
(isatuximab-irfc) / Sanofi
coltuximab ravtansine
(SAR3419) / AbbVie
lorvotuzumab mertansine
(IMGN901) / AbbVie
